SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment and delivery systems for injectable drugs, serving the pharmaceutical, biotechnology, and life sciences industries worldwide. Its product portfolio includes glass and polymer syringes such as syriQ, syriQ BioPure, SCHOTT TOPPAC, and their variants, as well as pharmaceutical glass cartridges, vials, and ampoules. The company also offers services in containment and drug delivery, analytics, fill-and-finish, regulatory affairs, and sustainability. Founded in 1884 and headquartered in Mainz, Germany, it operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.